These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7483659)

  • 21. Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.
    Haining RL; Hunter AP; Veronese ME; Trager WF; Rettie AE
    Arch Biochem Biophys; 1996 Sep; 333(2):447-58. PubMed ID: 8809086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsubstrate recognition site residues are involved in testosterone hydroxylation by cytochrome P450 CYP 2C11.
    Biagini CP; Philpot RM; Célier CM
    Arch Biochem Biophys; 1999 Jan; 361(2):309-14. PubMed ID: 9882461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of 3-dimensional homology modeling of cytochrome P450 2B1 for interpretation of site-directed mutagenesis results.
    Szklarz GD; Ornstein RL; Halpert JR
    J Biomol Struct Dyn; 1994 Aug; 12(1):061-78. PubMed ID: 7848559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The roles of individual amino acids in altering substrate specificity of the P450 2a4/2a5 enzymes.
    Negishi M; Uno T; Honkakoski P; Sueyoshi T; Darden TA; Pedersen LP
    Biochimie; 1996; 78(8-9):685-94. PubMed ID: 9010596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-function analysis of CYP2A10 and CYP2A11, P450 cytochromes that differ in only eight amino acids but have strikingly different activities toward testosterone and coumarin.
    Ding X; Peng HM; Coon MJ
    Biochem Biophys Res Commun; 1994 Aug; 203(1):373-8. PubMed ID: 8074681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.
    Negishi M; Iwasaki M; Juvonen RO; Aida K
    J Steroid Biochem Mol Biol; 1992 Dec; 43(8):1031-6. PubMed ID: 22217847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid metabolism by constitutive cytochromes P450.
    Schenkman JB
    J Steroid Biochem Mol Biol; 1992 Dec; 43(8):1023-30. PubMed ID: 22217846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Putative helix F contributes to regioselectivity of hydroxylation in mitochondrial cytochrome P450 27A1.
    Pikuleva IA; Puchkaev A; Björkhem I
    Biochemistry; 2001 Jun; 40(25):7621-9. PubMed ID: 11412116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-directed mutagenesis of cytochrome P450s CYP2A1 and CYP2A2: influence of the distal helix on the kinetics of testosterone hydroxylation.
    Hanioka N; Gonzalez FJ; Lindberg NA; Liu G; Gelboin HV; Korzekwa KR
    Biochemistry; 1992 Apr; 31(13):3364-70. PubMed ID: 1554718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key substrate recognition residues in the active site of a plant cytochrome P450, CYP73A1. Homology guided site-directed mutagenesis.
    Schoch GA; Attias R; Le Ret M; Werck-Reichhart D
    Eur J Biochem; 2003 Sep; 270(18):3684-95. PubMed ID: 12950252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering mouse P450coh to a novel corticosterone 15 alpha-hydroxylase and modeling steroid-binding orientation in the substrate pocket.
    Iwasaki M; Darden TA; Pedersen LG; Davis DG; Juvonen RO; Sueyoshi T; Negishi M
    J Biol Chem; 1993 Jan; 268(2):759-62. PubMed ID: 8419350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4.
    Lewis DF; Lake BG; Dickins M; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Xenobiotica; 1999 Apr; 29(4):361-93. PubMed ID: 10375007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Directed-evolution analysis of human cytochrome P450 2A6 for enhanced enzymatic catalysis.
    Lee H; Kim JH; Han S; Lim YR; Park HG; Chun YJ; Park SW; Kim D
    J Toxicol Environ Health A; 2014; 77(22-24):1409-18. PubMed ID: 25343290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimeric cDNA expression and site directed mutagenesis studies of cytochrome P450s CYP2A1 and CYP2A2.
    Hanioka N; Gonzalez FJ; Lindberg NA; Liu G; Korzekwa KR
    J Steroid Biochem Mol Biol; 1992 Dec; 43(8):1037-43. PubMed ID: 22217848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template.
    Lewis DF
    J Inorg Biochem; 2002 Sep; 91(4):502-14. PubMed ID: 12237218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Explicit water near the catalytic I helix Thr in the predicted solution structure of CYP2A4.
    Gorokhov A; Negishi M; Johnson EF; Pedersen LC; Perera L; Darden TA; Pedersen LG
    Biophys J; 2003 Jan; 84(1):57-68. PubMed ID: 12524265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 substrate interactions.
    Lewis DF; Lake BG; Dickins M; Goldfarb PS
    Xenobiotica; 2004 Jun; 34(6):549-69. PubMed ID: 15277015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct Regioselectivity of Fungal P450 Enzymes for Steroidal Hydroxylation.
    Lu W; Feng J; Chen X; Bao YJ; Wang Y; Wu Q; Ma Y; Zhu D
    Appl Environ Microbiol; 2019 Sep; 85(18):. PubMed ID: 31324634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of amino acid residues participated in substrate recognition by cytochrome P450 subfamilies with broad substrate specificity.
    Zharkova MS; Sobolev BN; Yu Oparina N; Veselovsky AV; Archakov AI
    J Mol Recognit; 2013 Feb; 26(2):86-91. PubMed ID: 23334916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.